Linguamatics joins Microsoft BioIT Alliance

Linguamatics Ltd., a provider of enterprise text mining for life science researchers, announced in June that it has joined the Microsoft BioIT Alliance, an association of life science organizations and informatics companies whose focus is to enhance collaboration and accelerate the pace of drug discovery and development.

CAMBRIDGE, England—Linguamatics Ltd., a provider of enterprise text mining for life science researchers, announced in June that it has joined the Microsoft BioIT Alliance, an association of life science organizations and informatics companies whose focus is to enhance collaboration and accelerate the pace of drug discovery and development.

"As the amount of textual information impacting drug discovery and development programs grows exponentially each year, the ability to extract and share decision-relevant knowledge is crucial to streamline the process and raise productivity," says Linguamatics COO and Co-Founder Roger Hale. "Linguamatics is delighted to be part of Microsoft's BioIT Alliance. As a leader in knowledge discovery from text, we look forward to working with other alliance members to explore new ways in which the immense value of text mining can be exploited across complex, multi-disciplinary organizations like pharmaceutical companies."

Formed in 2006, the BioIT Alliance is a cross-industry group whose founding members include Accelrys Software Inc., Affymetrix Inc., Agilent Technologies Inc., Amylin Pharmaceuticals Inc., Applied Biosystems, The BioTeam Inc., Digipede Technologies LLC, Discovery Biosciences Corp., Geospiza Inc., Hewlett-Packard Development Co. L.P., Illumina Inc., InterKnowlogy, Microsoft Corp., Sun Microsystems Inc., The Scripps Research Institute, VizX Labs LLC and other key companies in the pharmaceutical, biotech, hardware and software industries. DDN


Published In:


Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

February 2023 Front Cover

Latest Issue  

• Volume 19 • Issue 2 • February 2023

February 2023

February 2023 Issue